Creon (pancrelipase) may be a combination of 3 enzymes (proteins): enzyme, protease, and enzyme. These enzymessquare measure ordinarily created by the duct gland and square measure vital within the digestion of fats, proteins, and sugars.

Creon is employed to interchange these enzymes once the body doesn’t have enough of its own. sure medical conditions will cause this lack of enzymes, together with monogenic disorder, chronic inflammation of the duct gland, or blockage of the exocrine gland ducts.

Creon may additionally be used following surgical removal of the duct gland.

Creon may additionally be used for functions ex-directory during this medication guide.

Submit your review
1
2
3
4
5
Submit
     
Cancel

Create your own review

Average rating:  
 0 reviews
  • Creon, Pancrecarb, Pertzye, Ultrase, Viokase, Zenpep
  • Get emergency medical help if you have any of these signs of an allergic reaction to Creon: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

    Call your doctor at once if you have severe or unusual stomach pain. This could be a symptom of a rare but serious bowel disorder.

    Common Creon side effects may include:

    nausea or vomiting;
    mild stomach pain or upset;
    diarrhea or constipation;
    bloating or gas;
    greasy stools;
    rectal irritation;
    headache, dizziness;
    cough; or
    weight loss.
  • Dosage recommendations for pancreatic enzyme replacement therapy were published following the Cystic Fibrosis Foundation Consensus Conferences.1, 2, 3 CREON should be administered in a manner consistent with the recommendations of the Cystic Fibrosis Foundation Consensus Conferences (also known as Conferences) provided in the following paragraphs, except for infants. Although the Conferences recommend doses of 2,000 to 4,000 lipase units in infants up to 12 months, CREON is available in a 3,000 lipase unit capsule. Therefore, the recommended dose of CREON in infants up to 12 months is 3,000 lipase units per 120 mL of formula or per breast-feeding. Patients may be dosed on a fat ingestion-based or actual body weight-based dosing scheme.